• 简

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Kenvue (KVUE) Stock Still Looks Undervalued On Its 16% Gain

    Simply Wall St·10/02/2026 18:28:18
    语音播报

    Kenvue has delivered a 16.1% gain over the past year, even as shorter term returns have been softer. That naturally puts the focus on whether that move lines up with the cash the business can generate over time. With a Discounted Cash Flow (DCF) lens available, the key question is how closely the current US$17.22 share price aligns with the intrinsic value implied by those future cash streams.

    • The 16.1% return over the past year raises the question of whether Kenvue's recent share price strength is fully backed by its underlying cash generation.
    • For a consumer health company that depends on established brands and steady demand, a central issue is how efficiently profits convert into free cash flow that can support reinvestment and shareholder returns.
    • Prefer to judge Kenvue on earnings? See why Kenvue's 19.9x P/E tells a different valuation story.

    The issue now is whether Kenvue's current share price is adequately supported by the cash flows implied in the intrinsic value estimate from its Discounted Cash Flow (DCF) model.

    If you want to test the same cash flow lens beyond Kenvue, you can compare it with companies in the 28 high quality undervalued stocks

    Is Kenvue a Bargain on Cash Flow?

    The Discounted Cash Flow (DCF) model here takes Kenvue’s projected cash generation and brings it back to today’s dollars. Over the latest twelve months the business produced about $1.84b in free cash flow, which the model then carries forward using a gradually rising stream of future cash flows rather than any sharp jumps.

    Those projections extend through the next decade and assume Kenvue keeps converting earnings into cash at a level consistent with a mature consumer health group, without relying on aggressive expansion. When those future flows are discounted back, the model suggests an intrinsic value that is substantially above the current $17.22 share price. This indicates a wider gap between price and the cash flows implied for long term holders than the recent share price performance alone might suggest. Find out what Kenvue could be worth using our Discounted Cash Flow (DCF) estimate.

    The Kenvue Narrative: What Would Justify Today's Price?

    Narratives on Simply Wall St pick up where Kenvue's DCF puzzle leaves off by spelling out which future paths for growth, profitability and earnings would need to play out for the current valuation to look either restrained or stretched. Each scenario links its number to a clear view on how Kenvue's expansion prospects, margin profile and key risks might evolve, giving you something concrete to revisit as new information comes through.

    One of the top community narratives on Kenvue: 12% undervalued

    "The main factor that has to go right is execution on the planned $2.1b EBITDA synergy program and ongoing portfolio pruning…"

    Discover why this Narrative puts Kenvue at 12% undervalued.

    One more Kenvue check that belongs beside the cash flow math

    Price and cash tell only part of the story for Kenvue, because the people setting priorities, incentives and pay structures can tilt long term outcomes in ways the DCF cannot show on its own. See who runs Kenvue and how they are paid.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.